Metraipolis › archive › dc_be67da3e46b4

Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41623908
DOI
10.1210/jendso/bvaf224
License (as archived)
solo-consultazione
Archived
2026-11-06T10:13:11.827Z
SHA-256 of the archived text
4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9
Stable URL of this page
https://metraipolis.com/documento/dc_be67da3e46b4

How to cite

Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908 — Europe PMC (en), https://europepmc.org/article/MED/41623908 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be67da3e46b4 (Metraipolis archive dc_be67da3e46b4, sha256 4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9)
BibTeX
@misc{dcbe67da3e46b4,
  title = {Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41623908},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be67da3e46b4; sha256 4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41623908. Agents can read the archived copy with the MCP tool read_document.